RxDoctor Payments Data

Abhay Sanan, MD

Neurological Surgery · Tucson, AZNPI 1366411019

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.5% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $1,719 and has fallen 70.7% since, to $503 in 2025. That places this record below the midpoint for neurological surgery clinicians in AZ, where the typical reported total is $3,798.

$4,223in general payments, 2019–2025

Across 85 payments — averaging $49.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • UCB, Inc.$156
  • AbbVie$151
  • Globus Medical$106
  • Argenx US, Inc.$98
  • EMD Serono, Inc.$87
  • plus $563 from 22 others
$3,514in research payments, 2019–2025

Across 3 payments — averaging $1171.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arbor Pharmaceuticals, Inc.$4K
$224,579in ownership & investment interests, 2019–2025

Across 14 payments — averaging $16,041 each. An ownership or investment interest held by the physician or an immediate family member.

  • Synapse Surgical LLC$225K

What the payments were for

  • Travel & lodging$2,30655%
  • Food & beverage$1,91045%
  • Education$80%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,223 in reported general payments places this provider in the 50th percentile of 173 neurological surgery providers in Arizona.

See all neurological surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$193,454
Medicare patients
261
Services billed
2,044

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Carbamazepine13$862
Oxcarbazepine11$279
Levetiracetam12$239
Alprazolam13$9

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →